You are here

OARSI World Congress China Night

OARSI China Evening Session 2019 was held successfully in Canada

Prof. Changhai Ding is delivering a speech

The 2019 Osteoarthritis Research Society International (OARSI) China Evening Session was held successfully at Sheraton Center in Toronto, Canada on May 3, 2019. More than 60 attendees across China and around the globe came to this session to discuss advances in clinical and basic research of osteoarthritis (OA). The scientific programme included presentations given by prestigious Chinese professors as well as 3-minute speech contests delivered by 12 excellent young investigators in the field of OA. The presentation topics ranged from epidemiological and etiological research to latest developments in diagnosis and treatment of OA. 

Top prize winner of 3-mins speech contest-Jennifer Tzu-Chieh (3rd right)

This event is co-organized by OARSI and International Chinese Osteoarthritis Research Society (ICOARS), and co-Chaired by Prof. Changhai Ding (OARSI Board member, Director of Clinical Research Centre of Zhujiang Hospital of Southern Medical University) and Prof. Jianhao Lin (Chair of OARSI Asian Alliance Committee, Director of Department for Arthritis Clinic and Research Centre at People’s Hospital, Peking University). Initiated in 2014, the OARSI China Evening has been held successfully in the past 6 years and has become an indispensable component of OARSI annual meetings. 

“As the largest OA society in the world, China has more than 100 millions OA patients”, said Prof. Changhai Ding, “The Chinese OA research society has been growing year by year in term of research output, and it is crucial for Chinese researchers, especially young investigators, to collaborate with OARSI which is the premier international organization devoted to OA research and treatment.”

Group photo of ICOARS

The meeting concluded successfully on May, 2019, received enthusiastic responses from the audiences and attracted a wide attention of the media in China. The organizing and scientific committee of The 2019 China Evening Session would like to extend their gratitude to Mylan, Pfizer and those who contributed to the success of this forum. Your support and participation helped to make an incredible scientific gathering. Best wishes and see you again next year!

Featured Resources

OARSI White Paper- OA as a Serious Disease

By Various

Patient Summary- Non Surgical Treatment of Knee Osteoarthritis

By Multiple Authors